Table 4.
Comorbidity present in the patient group.
| Comorbidity | Number | Percentage |
|---|---|---|
| No comorbidity | 8 | 10.8% |
| IBD | 22 | 29.7% |
| Mb Crohn | 14 | 18.9% |
| Ulcerous colitis | 8 | 10.8% |
| Autoimmune disease | 10 | 13.5% |
| SLE | 4 | 5.4% |
| Myasthenia gravis | 2 | 2.7% |
| Sjogren's syndrome | 1 | 1.4% |
| Myositis (inflammatory-/dermatomyositis) | 2 | 2.7% |
| Granulomatosis with polyangiitis | 1 | 1.4% |
| Malignancy | 8 | 10.8% |
| AML | 1 | 1.4% |
| ALL | 3 | 4.1% |
| CLL | 1 | 1.4% |
| Other | 3 | 4.1% |
| Infection | 7 | 9.5% |
| HIV/AIDS | 5 | 6.8% |
| Endocarditis | 1 | 1.4% |
| Tuberculosis | 1 | 1.4% |
| Transplant recipients | 15 | 20.3% |
| Kidney | 9 | 12.2% |
| Liver | 1 | 1.4% |
| Stem cell transplant | 5 | 6.8% |
| Allogeneic | 3 | 4.1% |
| Autologous | 2 | 2.7% |
| Lifestyle associated conditions | 8 | 10.8% |
| Obesity | 2 | 2.7% |
| Diabetes type II | 2 | 2.7% |
| Hypertension | 3 | 4.1% |
| Hyperlipidemia | 1 | 1.4% |
| Pregnancy | 2 | 2.7% |
| Other (IBS, GATA mutation, AOSD, Bipolar | 8 | 10.8% |
| disorder, LETM, and heart failure) |
IBD, inflammatory bowel syndrome; SLE, systemic lupus erythematosus; AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; HIV, human immunodeficiency virus; AIDS, acute immunodeficiency syndrome; IBS, irritable bowel syndrome; AOSD, adult-onset Still's disease; LETM, longitudinal extensive transverse myelitis.